Shufeng Li

4.6k total citations
94 papers, 2.3k citations indexed

About

Shufeng Li is a scholar working on Epidemiology, Dermatology and Molecular Biology. According to data from OpenAlex, Shufeng Li has authored 94 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 23 papers in Dermatology and 18 papers in Molecular Biology. Recurrent topics in Shufeng Li's work include Inflammatory Myopathies and Dermatomyositis (12 papers), Sexual function and dysfunction studies (10 papers) and Cutaneous lymphoproliferative disorders research (9 papers). Shufeng Li is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (12 papers), Sexual function and dysfunction studies (10 papers) and Cutaneous lymphoproliferative disorders research (9 papers). Shufeng Li collaborates with scholars based in United States, Italy and China. Shufeng Li's co-authors include Leland W.K. Chung, David Fiorentino, Livia Casciola‐Rosen, Michael L. Eisenberg, Lisa C. Zaba, Anne Lynn S. Chang, Youn H. Kim, Lisa Christopher‐Stine, Andrew L. Mammen and Antony Rosen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Shufeng Li

87 papers receiving 2.3k citations

Peers

Countries citing papers authored by Shufeng Li

Since Specialization

Citations

This map shows the geographic impact of Shufeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shufeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shufeng Li more than expected).

Fields of papers citing papers by Shufeng Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shufeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shufeng Li. The network helps show where Shufeng Li may publish in the future.

Co-authorship network of co-authors of Shufeng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shufeng Li. A scholar is included among the top collaborators of Shufeng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shufeng Li. Shufeng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	5-alpha reductase inhibitors (5-ARi) with or without alpha-blockers (α-B) for Benign Prostatic Hyperplasia do NOT lower the risk of incident Bladder Cancer: United States insurance claims data 2023 ·World Journal of Urology ·Francesco Del Giudice, Federico Belladelli, Frank Glover, (unknown), Shufeng Li, (unknown), Benjamin Pradère, Francesco Soria, Wojciech Krajewski, Rajesh Nair, (unknown), (unknown), Michael L. Eisenberg	3
2	The Type I Interferon Signature Reflects Multiple Phenotypic and Activity Measures in Dermatomyositis 2023 ·Arthritis & Rheumatology ·(unknown), (unknown), (unknown), Shufeng Li, Christine Huard, Shanrong Zhao, Donald Bennett, Jillian G. Johnson, (unknown), Wen He, Janet E. Buhlmann, Karen Page, Kristen Johnson, Livia Casciola‐Rosen, Leland W.K. Chung, Kavita Y. Sarin, David Fiorentino	18
3	The Association Between Insomnia, Insomnia Medications, and Erectile Dysfunction 2023 ·European Urology Focus ·Federico Belladelli, Shufeng Li, (unknown), Francesco Del Giudice, (unknown), (unknown), Frank Glover, (unknown), Giuseppe Fallara, Francesco Montorsi, Andrea Salonia, Michael L. Eisenberg	8
4	Correlation of Ultraviolet Radiation Levels With the Incidence of Cutaneous Squamous Cell and Merkel Cell Carcinomas in Non-sunbelt Locales in the United States: 2010-2017 2023 ·Cureus ·(unknown), Shufeng Li, Gabriel Oh, (unknown), (unknown), Caroline Park, Anne Lynn S. Chang	1
5	Preconception paternal comorbidities and offspring birth defects: Analysis of a large national data set 2022 ·Birth Defects Research ·Bo Yu, Chiyuan Amy Zhang, Shufeng Li, Tony Chen, (unknown), Gary M. Shaw, Michael L. Eisenberg	1
6	A global, cross-sectional survey of patient-reported outcomes, disease burden, and quality of life in epidermolysis bullosa simplex 2022 ·Orphanet Journal of Rare Diseases ·(unknown), (unknown), (unknown), Shufeng Li, Jaron Nazaroff, Emily S. Gorell, Mark P. de Souza, Dédée F. Murrell, Joyce Teng, Albert S. Chiou, Jean Y. Tang	8
7	The Association Between Hemoglobin A1c Levels and Inflatable Penile Prosthesis Infection: Analysis of US Insurance Claims Data 2021 ·The Journal of Sexual Medicine ·Tony Chen, Shufeng Li, Michael L. Eisenberg	5
8	Association of preconception paternal health and adverse maternal outcomes among healthy mothers 2021 ·American Journal of Obstetrics & Gynecology MFM ·Gayathree Murugappan, Shufeng Li, Stephanie A. Leonard, Virginia D. Winn, Maurice L. Druzin, Michael L. Eisenberg	11
9	Rituximab Versus Mycophenolate in the Treatment of Recalcitrant Connective Tissue Disease–Associated Interstitial Lung Disease 2020 ·ACR Open Rheumatology ·(unknown), Melody P. Chung, (unknown), H. Henry Guo, (unknown), Shufeng Li, Susan S. Jacobs, Julie Morisset, Joshua J. Mooney, Rishi Raj, Leland W.K. Chung	6
10	Patient-reported outcomes and quality of life in recessive dystrophic epidermolysis bullosa: A global cross-sectional survey 2020 ·Journal of the American Academy of Dermatology ·(unknown), D. Solis, Emily S. Gorell, Sara Choi, Jaron Nazaroff, Shufeng Li, Mark P. de Souza, Dédée F. Murrell, M. Peter Marinkovich, Jean Y. Tang	28
11	Demographics, Usage Patterns, and Safety of Male Users of Clomiphene in the United States 2019 ·The World Journal of Men s Health ·(unknown), Dimitar V. Zlatev, Shufeng Li, Laurence C. Baker, Michael L. Eisenberg	6
12	Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study 2018 ·Journal of the American Academy of Dermatology ·Anne Lynn S. Chang, Duy Tran, (unknown), Shufeng Li, (unknown), Roma Patel, (unknown), (unknown), (unknown), Kerri E. Rieger, Ansuman T. Satpathy, Kathryn E. Yost, Sunil Reddy, Kavita Y. Sarin, A. Dimitrios Colevas	78
13	Cutaneous and Systemic Findings Associated With Nuclear Matrix Protein 2 Antibodies in Adult Dermatomyositis Patients 2017 ·Arthritis Care & Research ·(unknown), Leland W.K. Chung, Shufeng Li, Livia Casciola‐Rosen, David Fiorentino	79
14	Association Between Programmed Death Ligand 1 Expression in Patients With Basal Cell Carcinomas and the Number of Treatment Modalities 2017 ·JAMA Dermatology ·Julia Chang, Gefei Alex Zhu, (unknown), Shufeng Li, Jinah Kim, Anne Lynn S. Chang	42
15	Variability in the Expression of Immunohistochemical Markers: Implications for Biomarker Interpretation in Cutaneous T-Cell Lymphoma 2017 ·Journal of Investigative Dermatology ·Ziba Rahbar, Shufeng Li, Mahkam Tavallaee, Roberto A. Novoa, Jinah Kim, Youn H. Kim	12
16	Characterization of the peripheral neuropathy associated with brentuximab vedotin treatment of Mycosis Fungoides and Sézary Syndrome 2017 ·Journal of Neuro-Oncology ·Zachary Corbin, (unknown), Shufeng Li, Ziba Rahbar, Mahkam Tavallaee, Hannes Vogel, Katrin A. Salva, Gary S. Wood, Youn H. Kim, Seema Nagpal	27
17	Increased Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma 2016 ·JAMA Dermatology ·Shalini Mohan, Julia Chang, Shufeng Li, (unknown), Douglas Wood, Anne Lynn S. Chang	85
18	The Relationship Between Offspring Sex Ratio and Vasectomy Utilization 2016 ·Urology ·(unknown), (unknown), Shufeng Li, Michael L. Eisenberg	9
19	Low rate of dermatology outpatient visits in Asian-Americans: an initial survey study for associated patient-related factors 2014 ·BMC Dermatology ·Bharathi Lingala, Shufeng Li, Ashley Wysong, Allison Truong, David Kim, Anne Lynn S. Chang	14
20	Most Patients With Cancer‐Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP‐2 or Transcription Intermediary Factor 1γ 2013 ·Arthritis & Rheumatism ·David Fiorentino, Leland W.K. Chung, Lisa Christopher‐Stine, Lisa C. Zaba, Shufeng Li, Andrew L. Mammen, Antony Rosen, Livia Casciola‐Rosen	261

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact